no author cited
December 26, 2018


The U.S. Food and Drug Administration has approved VAXELIS™ (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate [Meningococcal Protein Conjugate] and Hepatitis B [Recombinant] Vaccine) for use in children from 6 weeks through 4 years of age (prior to the 5th birthday). VAXELIS was developed as part of a joint-partnership between Sanofi (NYSE: SNY) and Merck (NYSE: MRK), known as MSD outside the United States and Canada.

Keep reading: https://www.streetinsider.com/Corpor...EK_tz90XY4nlpg